Introduction: With increasing availability of pathogen genetic and especially whole-genome sequence data, there is a pressing need for analytical tools and innovative approaches to make use of them. In particular, methods for using genomic data to make inferences about transmission chains and pathogen evolution under selection by host immunity, vaccines, and antibiotics, are still in their infancy. These questions are fundamentally different from the types of questions asked when examining one sequence at a time, which illuminate the biology of conserved aspects of infection and pathogenesis. Population genomic studies shed light on population heterogeneity in the pathogen, its consequences and causes. These inferences naturally lend themselves to the estimation of parameters for transmission-dynamic models and, even more fundamentally, to the determination of how such models should be structured, and the testing of their predictions. To date, using MIDAS and non-MIDAS funding for analytic efforts, and non-MIDAS funding for the costs of sequencing, we have made a number of significant discoveries over the last five years using pathogen population genomics and genetics, and we have identified many opportunities to improve and expand methods over the next five years, as well as to apply existing methods to significant questions of biology and epidemiology.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54GM088558-06
Application #
8796407
Study Section
Special Emphasis Panel (ZGM1-BBCB-5 (MI))
Project Start
Project End
Budget Start
2014-09-20
Budget End
2015-08-31
Support Year
6
Fiscal Year
2014
Total Cost
$66,108
Indirect Cost
$25,174
Name
Harvard University
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Wesolowski, Amy; Winter, Amy; Tatem, Andrew J et al. (2018) Measles outbreak risk in Pakistan: exploring the potential of combining vaccination coverage and incidence data with novel data-streams to strengthen control. Epidemiol Infect 146:1575-1583
Goldstein, Edward; Nguyen, Hieu H; Liu, Patrick et al. (2018) On the Relative Role of Different Age Groups During Epidemics Associated With Respiratory Syncytial Virus. J Infect Dis 217:238-244
Lam, Ha Minh; Wesolowski, Amy; Hung, Nguyen Thanh et al. (2018) Nonannual seasonality of influenza-like illness in a tropical urban setting. Influenza Other Respir Viruses 12:742-754
Yang, Juan; Lau, Yiu Chung; Wu, Peng et al. (2018) Variation in Influenza B Virus Epidemiology by Lineage, China. Emerg Infect Dis 24:1536-1540
Hitchings, Matt D T; Lipsitch, Marc; Wang, Rui et al. (2018) Competing Effects Of Indirect Protection And Clustering On The Power Of Cluster-Randomized Controlled Vaccine Trials. Am J Epidemiol :
Kahn, Rebecca; Hitchings, Matt; Bellan, Steven et al. (2018) Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials. Clin Trials 15:207-211
Liu, Yang; Lam, Kwok-Fai; Wu, Joseph T et al. (2018) Geographically weighted temporally correlated logistic regression model. Sci Rep 8:1417
Zhang, Hongjun; Xiong, Qian; Wu, Peng et al. (2018) Influenza-associated mortality in Yancheng, China, 2011-15. Influenza Other Respir Viruses 12:98-103
Lewnard, Joseph A; Tedijanto, Christine; Cowling, Benjamin J et al. (2018) Measurement of Vaccine Direct Effects Under the Test-Negative Design. Am J Epidemiol 187:2686-2697
Babu, Tara M; Perera, Ranawaka A P M; Wu, Joseph T et al. (2018) Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis 218:1054-1060

Showing the most recent 10 out of 462 publications